471 related articles for article (PubMed ID: 33513753)
1. iPSC-Derived Hereditary Breast Cancer Model Reveals the
Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene.
Griscelli F; Oudrhiri N; Feraud O; Divers D; Portier L; Turhan AG; Bennaceur Griscelli A
Stem Cell Res; 2017 Oct; 24():135-138. PubMed ID: 29034880
[TBL] [Abstract][Full Text] [Related]
3. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Spitzhorn LS; Megges M; Wruck W; Rahman MS; Otte J; Degistirici Ö; Meisel R; Sorg RV; Oreffo ROC; Adjaye J
Stem Cell Res Ther; 2019 Mar; 10(1):100. PubMed ID: 30885246
[TBL] [Abstract][Full Text] [Related]
4. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
6. Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome.
Wang S; Umrath F; Cen W; Salgado AJ; Reinert S; Alexander D
Cells; 2022 Mar; 11(6):. PubMed ID: 35326438
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.
Liu B; Chen F; Wu Y; Wang X; Feng M; Li Z; Zhou M; Wang Y; Wu L; Liu X; Liang D
Oncotarget; 2017 Jun; 8(25):40791-40803. PubMed ID: 28388559
[TBL] [Abstract][Full Text] [Related]
8. Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Accelerate Skin Cell Proliferation.
Kim S; Lee SK; Kim H; Kim TM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314356
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
10. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
11. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
[TBL] [Abstract][Full Text] [Related]
12. DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers.
Vaclová T; Gómez-López G; Setién F; Bueno JM; Macías JA; Barroso A; Urioste M; Esteller M; Benítez J; Osorio A
Breast Cancer Res Treat; 2015 Jul; 152(2):271-82. PubMed ID: 26071757
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.
Wang JC; Li GY; Wang B; Han SX; Sun X; Jiang YN; Shen YW; Zhou C; Feng J; Lu SY; Liu JL; Wang MD; Liu PJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):235. PubMed ID: 31164151
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression.
Zhao R; Kaakati R; Liu X; Xu L; Lee AK; Bachelder R; Li CY; Hollenbeck ST
Plast Reconstr Surg; 2019 Mar; 143(3):747-756. PubMed ID: 30817646
[TBL] [Abstract][Full Text] [Related]
15. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
[TBL] [Abstract][Full Text] [Related]
16. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
17. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
18. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
